<DOC>
	<DOC>NCT00550121</DOC>
	<brief_summary>In CHF central sympathetic activity is increased. ROS formation seems to play a role in this process. This study analyzes the effect of vitamin C as an antioxidant on central sympathetic activity in CHF</brief_summary>
	<brief_title>Does Ascorbic Acid Reduce Sympathoexcitation in CHF?</brief_title>
	<detailed_description />
	<mesh_term>Heart Failure</mesh_term>
	<criteria>Heart failure of at least New York Heart Association (NYHA) class II Left ventricular ejection fraction (LVEF) &lt;= 40% Age 2080 years Necessity of shortterm PCI, CABG or heart transplantation, Chronic disease of the autonomic nervous system, diabetes mellitus, use of tricyclic antidepressant drugs and/or aadrenergic receptor antagonists.</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>October 2008</verification_date>
</DOC>